Understanding how erythroferrone affects iron metabolism and anemia
MECHANISM OF ACTION OF ERYTHROFERRONE AND PATHOLOGICAL IMPLICATIONS
This study is looking at a hormone called erythroferrone that helps control iron in the body, to better understand how it affects people with anemia and other blood-related issues, using special mice to see how different amounts of this hormone impact health.
Quick facts
| Grant type | R01 grant |
|---|---|
| Study type | NIH-funded research |
| Funding institution | University of California Los Angeles NIH-funded |
| Lab location | 1 site (Los Angeles, United States) |
| Project ID | NIH-10890117 on NIH RePORTER |
What this research studies
This research investigates the role of erythroferrone, a hormone produced by erythroblasts, in regulating iron metabolism and its implications for conditions like anemia. By studying how erythroferrone interacts with bone morphogenetic proteins, the research aims to uncover the mechanisms that lead to iron overload and other systemic effects in patients with ineffective erythropoiesis. The team will utilize transgenic mouse models to explore the consequences of varying levels of erythroferrone on blood and overall health. This approach may provide insights into new treatment strategies for anemia and related disorders.
Who could benefit from this research
Good fit: Ideal candidates for this research include individuals suffering from anemia, particularly those with conditions characterized by ineffective erythropoiesis.
Not a fit: Patients with anemia due to causes unrelated to erythropoiesis or iron metabolism may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to improved treatments for anemia and better management of iron levels in patients.
How similar studies have performed: Previous research has shown promising results in understanding the role of hormones like erythroferrone in iron metabolism, indicating potential for success in this area.
Where this research is happening
Los Angeles, United States
- University of California Los Angeles — Los Angeles, United States (Active)
Researchers
- Principal investigator: Ganz, Tomas — University of California Los Angeles
- Study coordinator: Ganz, Tomas
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.